Whitebox Advisors’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Whitebox Advisors’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-75,000	Closed	-$767K	–	570
2023 Q1	$767K	Hold	75,000	–	–	0.03%	209
2022 Q4	$754K	Hold	75,000	–	–	0.02%	337
2022 Q3	$738K	Hold	75,000	–	–	0.02%	421
2022 Q2	$730K	Hold	75,000	–	–	0.02%	412
2022 Q1	$731K	Hold	75,000	–	–	0.01%	440
2021 Q4	$725K	Hold	75,000	–	–	0.01%	440
2021 Q3	$737K	Buy	+75,000	New	+$732K	0.02%	334

Whitebox Advisors's ORIA Position: Q2 2023 in Review

Whitebox Advisors sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 75,000 shares — an estimated $767K sold.

Whitebox Advisors first reported a position in ORIA in Q3 2021 and held it in 7 quarters. The position peaked at $767K in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

Whitebox Advisors reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
Whitebox Advisors sold 75,000 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $767K.
Whitebox Advisors first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q3 2021 and held it in 7 quarters.
Whitebox Advisors's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $767K in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Whitebox Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.